Industrial Biotechnology (Inv. No. 332-481)

Forms and Documents

Forms and supporting documents for this ICR

Document	Type	Status	Availability
Form 332-481 Liquid Biofuel and Chemical Industry Questionnaire	Form	New	Available
Biotech--OMB Support Statement.wpd	Supporting Statement A	Uploaded 2007-08-28	Available
19 USC 1332.pdf	Supplementary Document	Uploaded 2007-08-28	Available
19 USC 1333.pdf	Supplementary Document	Uploaded 2007-08-28	Available
biotech_request_letter.pdf	Supplementary Document	Uploaded 2007-08-28	Available

IC Document Collections

Information collection document groups

IC ID	Collection	Type	Status	Form
181797	Liquid Biofuel and Chemical Industry Questionnaire	Form	New

ICR Details

OMB Control No: 3117-0217	ICR Reference No: 200708-3117-001
Status: Historical Active	Previous ICR Reference No:
Agency/Subagency: ITC	Agency Tracking No: 332-481
Title: Industrial Biotechnology (Inv. No. 332-481)
Type of Information Collection: New collection (Request for a new OMB Control Number)	Common Form ICR:  No
Type of Review Request: Emergency	Approval Requested By: 09/12/2007
OIRA Conclusion Action: Approved without change	Conclusion Date: 09/21/2007
	Date Received in OIRA: 08/28/2007
Terms of Clearance:

table that charts list comparision

	Inventory as of this Action	Requested	Previously Approved
Expiration Date	03/31/2008	6 Months From Approved
Responses	1,500	0	0
Time Burden (Hours)	60,000	0	0
Cost Burden (Dollars)	3,205,800	0	0

---

Abstract: The Senate Finance Committee has requested that the Commission prepare a report on the development and adoption of industrial biotechnology by the U.S. chemical and biofuel industries. The Commission is responsible for providing such reports on issues affecting trade and the U.S. domestic industry under Section 332 of the tariff Act of 1930. Questionnaire are needed to asses the impact of industrial biotechnology on the U.S. economy, and the competitive conditions affecting these industries.

Emergency Justfication: Under section 332 of the Tariff Act of 1930 (19 U.S.C. 1332), the Commission conducts investigations into trade and tariff matters at the request of the President, the U.S. House Committee on Ways and Means, and the U.S. Senate Committee on Finance. As noted above, the subject investigation was requested by the Senate Finance Committee with a deadline that necessitates prompt issuance of questionnaires. The Commission cannot reasonably comply with the normal clearance procedures under 5 CFR 1320.10(b) for this investigation. The biofuel and chemical industry questionnaires are tentatively scheduled to be mailed on or before September 14, 2007, in order to give the industry sufficient time to fill out the questionnaires, which are due back to the Commission by October 19, 2007. The collection of these data is integral to the successful fulfillment of the request of the Senate Finance Committee.

---

Authorizing Statute(s): US Code: 19 USC 1332 Name of Law: Investigations
   US Code: 19 USC 1333 Name of Law: Testimony and the Production of Papers
  

Citations for New Statutory Requirements: None

---

Associated Rulemaking Information
RIN:	Stage of Rulemaking:	Federal Register Citation:	Date:
	Not associated with rulemaking

---

Federal Register Notices & Comments

Did the Agency receive public comments on this ICR? No

---

Number of Information Collection (IC) in this ICR: 1

table that charts list of burden

IC Title	Form No.	Form Name
Liquid Biofuel and Chemical Industry Questionnaire	332-481	Liquid Biofuel and Chemical Industry Questionnaire

---

ICR Summary of Burden

table that charts list of burden

	Total Approved	Previously Approved	Change Due to New Statute	Change Due to Agency Discretion	Change Due to Adjustment in Estimate	Change Due to Potential Violation of the PRA
Annual Number of Responses	1,500	0	0	1,500	0	0
Annual Time Burden (Hours)	60,000	0	0	60,000	0	0
Annual Cost Burden (Dollars)	3,205,800	0	0	3,205,800	0	0

Burden increases because of Program Change due to Agency Discretion: Yes

Burden Increase Due to: Miscellaneous Actions

Burden decreases because of Program Change due to Agency Discretion: No

Burden Reduction Due to:

Short Statement: The burden increased because of a request from the Senate Finance Committee for a report on the development and adoption by the U.S. chemical and biofuel industry of industrial biotechnology. Such data is not publicly available. This is a one-time collection for such data. The request letter is attached as a supplemental document.

---

Annual Cost to Federal Government: $1,513,487

Does this IC contain surveys, censuses, or employ statistical methods? No

Is the Supporting Statement intended to be a Privacy Impact Assessment required by the E-Government Act of 2002? No

Is this ICR related to the Affordable Care Act [Pub. L. 111-148 & 111-152]? Uncollected

Is this ICR related to the Dodd-Frank Wall Street Reform and Consumer Protection Act, [Pub. L. 111-203]? Uncollected

Is this ICR related to the American Recovery and Reinvestment Act of 2009 (ARRA)? Uncollected

Is this ICR related to the Pandemic Response? Uncollected

---

Common Form ICR:  No

---

On behalf of this Federal agency, I certify that the collection of information encompassed by this request complies with 5 CFR 1320.9 and the related provisions of 5 CFR 1320.8(b)(3).

The following is a summary of the topics, regarding the proposed collection of information, that the certification covers:

(a) It is necessary for the proper performance of agency functions;

(b) It avoids unnecessary duplication;

(c) It reduces burden on small entities;

(d) It uses plain, coherent, and unambiguous language that is understandable to respondents;

(e) Its implementation will be consistent and compatible with current reporting and recordkeeping practices;

(f) It indicates the retention periods for recordkeeping requirements;

(g) It informs respondents of the information called for under 5 CFR 1320.8 (b)(3) about:

(i) Why the information is being collected;

(ii) Use of information;

(iii) Burden estimate;

(iv) Nature of response (voluntary, required for a benefit, or mandatory);

(v) Nature and extent of confidentiality; and

(vi) Need to display currently valid OMB control number;

(h) It was developed by an office that has planned and allocated resources for the efficient and effective management and use of the information to be collected.

(i) It uses effective and efficient statistical survey methodology (if applicable); and

(j) It makes appropriate use of information technology.

If you are unable to certify compliance with any of these provisions, identify the item by leaving the box unchecked and explain the reason in the Supporting Statement.

Certification Date: 08/28/2007

---